Creatinine Assay Kits Market by Type (Jaffe's Kinetic Test  Creatinine-PAP  and ELISA)  Sample (Blood  Serum  Urine  Saliva  CSF  Tissue Homogenate  Sweat) and Region (North America  Europe  Asia and RoW) - Global Forecast to 2022

Creatinine Assay Kits Market by Type (Jaffe's Kinetic Test Creatinine-PAP and ELISA) Sample (Blood Serum Urine Saliva CSF Tissue Homogenate Sweat) and Region (North America Europe Asia and RoW) - Global Forecast to 2022

MarketsandMarkets | ID: 1524184514602 | Published at: 2018-03-21 | Pages: 192

  • €4.785,63


“The global creatinine assay kits market projected to grow at a CAGR of 5.3%.”
The global creatinine assay kits market is expected to reach USD 245.4 million by 2022 from USD 189.6 million in 2017, at a CAGR of 5.3%

Growth in this market is mainly driven by the increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and advancements in biomedical research pertaining to kidney disorders. However, the limited usage of creatinine assay kits in IVD and identification of novel renal dysfunction biomarkers are expected to challenge market growth in the coming years.

“Creatinine-PAP test kits are expected to grow at the highest CAGR during the forecast period.”
Based on type, the market is segmented into Jaffe’s kinetic test kits, Creatinine-PAP test kits, and ELISA test kits. The Creatinine-PAP test kits segment is expected to grow at the highest CAGR during the forecast period. The fastest growth of this segment is attributed to the increasing demand for more accurate kits and high research funding support for renal research initiatives.

“The urine segment is expected to dominate the market during the forecast period.”
Based on type of sample, the creatinine assay kits market is segmented into blood/serum, urine, and other samples. The urine segment is expected to dominate the market during the forecast period. The large share of this segment can primarily be attributed to the greater preference for urine samples owing to the ease of sample collection.

“Asia to witness the highest growth during the forecast period.”

In 2017, North America accounted for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high prevalence of CKD and ESRD in this region and the presence of a large undiagnosed population are the major factors driving the growth of the creatinine assay kits market in Asia. The increasing prevalence of infectious diseases and metabolic syndromes in this region is resulting in the high and regular prescription for metabolic tests.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 33%; Tier 2 – 45%; Tier 3 – 22%
• By Designation C-level- 22%; D-level- 28%; Others- 50%
• By Region: North America-55%; Europe-24%; Asia -15%; Rest of the World-6%

List of companies profiled in the report
• Thermo Fisher Scientific (US)
• Merck (Germany)
• Abcam (UK)
• Abbott Laboratories (US)
• Quidel (US)
• Enzo Life Sciences (US)
• Cayman Chemical (US)
• Crystal Chem (US)
• Cell Biolabs (US)
• GenWay Biotech (US)
• BioAssay Systems (US)
• Wako Pure Chemical Industries (Japan)
• Tulip Diagnostics (India)
• BioVision (US)
• Arbor Assays (US)
Research Coverage:
The report provides an overview of the creatinine assay kits market. It aims at estimating the market size and future growth potential of this market across different segments such as type, type of sample, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall creatinine assay kits market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
    2 RESEARCH METHODOLOGY
  • 2.1 INTRODUCTION
  • 2.2 RESEARCH DATA
  • 2.3 MARKET SIZE ESTIMATION: CREATININE ASSAY KITS MARKET 2.3.1 BOTTOM-UP APPROACH 2.3.2 TOP-DOWN APPORACH
  • 2.4 BREAKDOWN OF PRIMARIES: CREATININE ASSAY KITS MARKET
  • 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION: CREATININE ASSAY KITS MARKET
  • 2.6 EPIDEMIOLOGY-BASED MODEL: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED
  • 2.7 BREAKDOWN OF PRIMARIES: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED
  • 2.8 MARKET BREAKDOWN AND DATA TRIANGULATION: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED
  • 2.9 SECONDARY DATA 2.9.1 KEY DATA FROM SECONDARY SOURCES
  • 2.10 PRIMARY DATA 2.10.1 KEY DATA FROM PRIMARY SOURCES
  • 2.11 ASSUMPTIONS
    3 EXECUTIVE SUMMARY
    4 PREMIUM INSIGHTS
    5 MARKET OVERVIEW
  • 5.1 INTRODUCTION
  • 5.2 MARKET DRIVERS 5.2.1 INCREASING INCIDENCE OF RENAL DISORDERS 5.2.2 GROWING INCIDENCE OF OTHER CHRONIC DISORDERS IMPACTING RENAL FUNCTION 5.2.3 GROWING AWARENESS AND ADOPTION OF PREVENTIVE HEALTHCARE 5.2.4 FAVORABLE GOVERNMENT INITIATIVES TO PROMOTE RENAL HEALTH 5.2.5 RAPID GROWTH IN THE GERIATRIC POPULATION 5.2.6 ADVANCEMENTS IN BIOMEDICAL RESEARCH PERTAINING TO KIDNEY DISORDERS
    AND AVAILABILITY OF FUNDING
  • 5.3 MARKET RESTRAINTS/CHALLENGES 5.3.1 LIMITED USAGE OF CREATININE ASSAY KITS IN IVD 5.3.2 IDENTIFICATION OF NOVEL RENAL DYSFUNCTION BIOMARKERS 5.3.3 FREQUENTLY CHANGING REGULATORY POLICIES
  • 5.4 MARKET OPPORTUNITIES 5.4.1 HIGH GROWTH POTENTIAL IN EMERGING ECONOMIES
    6 NUMBER OF CREATININE TESTS PERFORMED
  • 6.1 INTRODUCTION
  • 6.2 NUMBER OF CREATININE TESTS PERFORMED, BY REGION
  • 6.3 NUMBER OF CREATININE TESTS PERFORMED, BY TYPE
    7 CREATININE ASSAY KITS MARKET, BY TYPE
  • 7.1 INTRODUCTION
  • 7.2 JAFFE’S KINETIC TEST KITS
  • 7.3 CREATININE-PAP TEST KITS
  • 7.4 ELISA TEST KITS
    8 CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE
  • 8.1 INTRODUCTION
  • 8.2 BLOOD/SERUM
  • 8.3 URINE
  • 8.4 OTHER SAMPLES
    9 CREATININE ASSAY KITS MARKET, BY REGION
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA 9.2.1 U.S. 9.2.2 CANADA
  • 9.3 EUROPE 9.3.1 GERMANY 9.3.2 UK 9.3.3 FRANCE 9.3.4 REST OF THE EUROPE
  • 9.4 ASIA 9.4.1 JAPAN 9.4.2 CHINA 9.4.3 INDIA 9.4.4 INDONESIA 9.4.5 REST OF THE ASIA
  • 9.5 REST OF THE WORLD 9.5.1 BRAZIL 9.5.2 OTHER REST OF THE WORLD
    10 COMPETITIVE LANDSCAPE
  • 10.1 CREATININE ASSAY KITS MARKET: COMPETITIVE INTELLIGENCE (2016)
  • 10.2 MARKET SHARE ANALYSIS
  • 10.3 COMPETETIVE SITUATION & TRENDS
    11 COMPANY PROFILES
  • 11.1 INTRODUCTION
  • 11.2 THERMO FISHER SCIENTIFIC INC.
  • 11.3 MERCK KGAA
  • 11.4 ABCAM PLC
  • 11. 5 ABBOTT LABORATORIES
  • 11. 6 QUIDEL CORPORATION
  • 11.7 ENZO LIFE SCIENCES, INC.
  • 11.8 CAYMAN CHEMICAL
  • 11.9 CRYSTAL CHEM INC.
  • 11.10 CELL BIOLABS INC.
  • 11.11 GENWAY BIOTECH
  • 11.12 BIOASSAY SYSTEMS LLC
  • 11.13 WAKO PURE CHEMICAL INDUSTRIES, LTD
  • 11.14 TULIP DIAGNOSTICS PRIVATE LIMITED
  • 11.15 BIOVISION INC.
  • 11.16 ARBOR ASSAYS LLC

12 APPENDIX

  • 12.1 KEY INDUSTRY INSIGHTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.4 MARKETSANDMARKETS KNOWLEDGE STORE: SNAPSHOT
  • 12.5 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 12.6 RELATED REPORTS
  • 12.7 AUTHOR DETAILS

LIST OF TABLES

TABLE 1 NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY REGION 2016 (MILLION UNITS)
TABLE 2 JAFFE’S KINETIC TEST: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY REGION 2016 (MILLION UNITS)
TABLE 3 CREATININE-PAP TEST: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY REGION 2016 (MILLION UNITS)
TABLE 4 CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 5 JAFFE’S KINETIC TEST KITS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 6 NORTH AMERICA: JAFFE’S KINETIC TEST KITS MARKET, BY COUNTRY,
2015–2022 (USD MILLION)
TABLE 7 EUROPE: JAFFE’S KINETIC TEST KITS MARKET, BY COUNTRY,
2015–2022 (USD MILLION)
TABLE 8 ASIA: JAFFE’S KINETIC TEST KITS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 9 ROW: JAFFE’S KINETIC TEST KITS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 10 CREATININE-PAP TEST KITS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 11 NORTH AMERICA: CREATININE-PAP TEST KITS MARKET, BY COUNTRY,
2015–2022 (USD MILLION)
TABLE 12 EUROPE: CREATININE-PAP TEST KITS MARKET, BY COUNTRY,
2015–2022 (USD MILLION)
TABLE 13 ASIA: CREATININE-PAP TEST KITS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 14 ROW: CREATININE-PAP TEST KITS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 15 ELISA TEST KITS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 16 NORTH AMERICA: ELISA TEST KITS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 17 EUROPE: ELISA TEST KITS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 18 ASIA: ELISA TEST KITS MARKET, BY COUNTRY, 2015–2022 (USD THOUSAND)
TABLE 19 ROW: ELISA TEST KITS MARKET, BY COUNTRY, 2015–2022 (USD THOUSAND)
TABLE 20 CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
TABLE 21 BLOOD/SERUM SAMPLES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 22 NORTH AMERICA: BLOOD/SERUM SAMPLES MARKET, BY COUNTRY,
2015–2022 (USD MILLION)
TABLE 23 EUROPE: BLOOD/SERUM SAMPLES MARKET, BY COUNTRY,
2015–2022 (USD MILLION)
TABLE 24 ASIA: BLOOD/SERUM SAMPLES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 25 ROW: BLOOD/SERUM SAMPLES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 26 URINE SAMPLES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 27 NORTH AMERICA: URINE SAMPLES MARKET, BY COUNTRY,
2015–2022 (USD MILLION)
TABLE 28 EUROPE: URINE SAMPLES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 29 ASIA: URINE SAMPLES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 30 ROW: URINE SAMPLES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 31 OTHER SAMPLES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 32 NORTH AMERICA: OTHER SAMPLES MARKET, BY COUNTRY,
2015–2022 (USD MILLION)
TABLE 33 EUROPE: OTHER SAMPLES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 34 ASIA: OTHER SAMPLES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 35 ROW: OTHER SAMPLES MARKET, BY COUNTRY, 2015–2022 (USD THOUSAND)
TABLE 36 CREATININE ASSAY KITS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 37 NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE,
2016 (MILLION UNITS)
TABLE 38 NORTH AMERICA: CREATININE ASSAY KITS MARKET, BY COUNTRY,
2015–2022 (USD MILLION)
TABLE 39 NORTH AMERICA: CREATININE ASSAY KITS MARKET, BY TYPE,
2015–2022 (USD MILLION)
TABLE 40 NORTH AMERICA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD MILLION)
TABLE 41 US: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 42 US: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
TABLE 43 US: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE,
2016 (MILLION UNITS)
TABLE 44 CANADA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 45 CANADA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD MILLION)
TABLE 46 CANADA: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED,
BY TYPE, 2016 (MILLION UNITS)
TABLE 47 EUROPE: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 48 EUROPE: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD MILLION)
TABLE 49 EUROPE: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED,
BY TYPE 2016 (MILLION UNITS)
TABLE 50 GERMANY: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 51 GERMANY: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD MILLION)
TABLE 52 UK: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 53 UK: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
TABLE 54 FRANCE: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 55 FRANCE: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD MILLION)
TABLE 56 ROE: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 57 ROE: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
TABLE 58 ASIA: CREATININE ASSAY KITS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 59 ASIA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 60 ASIA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
TABLE 61 JAPAN: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 62 JAPAN: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD MILLION)
TABLE 63 JAPAN: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED,
BY TYPE 2016 (MILLION UNITS)
TABLE 64 CHINA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 65 CHINA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD MILLION)
TABLE 66 CHINA: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED,
BY TYPE, 2016 (MILLION UNITS)
TABLE 67 INDIA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 68 INDIA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD MILLION)
TABLE 69 INDIA: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED,
BY TYPE, 2016 (MILLION UNITS)
TABLE 70 INDONESIA: CREATININE ASSAY KITS MARKET, BY TYPE,
2015–2022 (USD THOUSAND)
TABLE 71 INDONESIA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD THOUSAND)
TABLE 72 INDONESIA: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED,
BY TYPE 2016 (MILLION UNITS)
TABLE 73 ROA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 74 ROA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
TABLE 75 ROA: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED,
BY TYPE, 2016 (MILLION UNITS)
TABLE 76 REST OF THE WORLD: CREATININE ASSAY KITS MARKET, BY COUNTRY,
2015–2022 (USD MILLION)
TABLE 77 REST OF THE WORLD: CREATININE ASSAY KITS MARKET, BY TYPE,
2015–2022 (USD MILLION)
TABLE 78 ROW: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015–2022 (USD MILLION)
TABLE 79 ROW: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED,
BY TYPE, 2016 (MILLION UNITS)
TABLE 80 BRAZIL: CREATININE ASSAY KITS MARKET, BY TYPE, 2015–2022 (USD THOUSAND)
TABLE 81 OTHER ROW COUNTRIES: CREATININE ASSAY KITS MARKET, BY TYPE,
2015–2022 (USD MILLION)
TABLE 82 BRAZIL: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD THOUSAND)
TABLE 83 BRAZIL: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED,
BY TYPE 2016 (MILLION UNITS)
TABLE 84 OTHER ROW COUNTRIES: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE,
2015–2022 (USD MILLION)


LIST OF FIGURES

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 YEARS CONSIDERED FOR THE STUDY
FIGURE 3 RESEARCH DESIGN
FIGURE 4 CREATININE ASSAY KITS MARKET: BOTTOM-UP APPROACH
FIGURE 5 CREATININE ASSAY KITS MARKET: TOP-DOWN APPROACH
FIGURE 6 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7 DATA TRIANGULATION METHODOLOGY: CREATININE ASSAY KITS MARKET
FIGURE 8 EPIDEMIOLOGY-BASED MODEL: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS: BY REGION
FIGURE 10 DATA TRIANGULATION METHODOLOGY: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED
FIGURE 11 CREATININE ASSAY KITS MARKET, BY TYPE, 2017 VS. 2022
FIGURE 12 CREATININE ASSAY KITS MARKET, BY TYPE OF SAMPLE, 2017 VS. 2022
FIGURE 13 GEOGRAPHIC SNAPSHOT OF THE CREATININE ASSAY KITS MARKET: ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 14 INCREASING INCIDENCE OF RENAL DISORDERS: MAJOR FACTOR DRIVING THE GROWTH OF THE CREATININE ASSAY KITS MARKET
FIGURE 15 JAFFE’S KINETIC TEST KITS SEGMENT TO DOMINATE THE MARKET IN 2017
FIGURE 16 URINE SAMPLES SEGMENT TO DOMINATE THE MARKET IN 2017
FIGURE 17 GEOGRAPHIC GROWTH OPPORTUNITIES: ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 18 CREATININE ASSAY KITS MARKET: DRIVERS, RESTRAINTS/CHALLENGES, AND OPPORTUNITIES
FIGURE 19 PRICING ANALYSIS: CREATININE TEST MARKET
FIGURE 20 KEY DEVELOPMENTS IN THE CREATININE ASSAY KITS MARKET, 2013–2017
FIGURE 21 AGREEMENTS ACCOUNTED FOR THE LARGEST SHARE OF THE TOTAL DEVELOPMENTS IN THE CREATININE ASSAY KITS MARKET (2013–2017)
FIGURE 22 INSIGHTS FROM INDUSTRY EXPERTS

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!